WHAT THE C@H?!

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Feb 2024 filing date already counts against anyone who files later.

Record

Serial number

98421458

Mark type

Stylized text

Filed

26 Feb 2024

Published for opposition

08 Apr 2025

Attorney of record

Allison Strickland Ricketts

Goods and services

• Class 035 — Advertising and business services: Promoting awareness of congenital adrenal hyperplasia and promoting awareness of congenital adrenal hyperplasia by providing a public in-person platform to discuss congenital adrenal hyperplasia and coping strategies; Promoting awareness of adrenal insufficiency and promoting awareness of adrenal insufficiency by providing a public in-person platform to discuss adrenal insufficiency and coping strategies; Promoting awareness of endocrine diseases and disorders and promoting awareness of endocrine diseases and disorders by providing a public in-person platform to discuss endocrine diseases and disorders and coping strategies; promoting the interests of people who have congenital adrenal hyperplasia and their families and health care providers by means of public advocacy; promoting the interests of people who have adrenal insufficiency and their families and health care providers by means of public advocacy; promoting the interests of people who have endocrine diseases and disorders and their families and health care providers by means of public advocacy; maintaining a registry of patients with congenital adrenal hyperplasia; maintaining a registry of patients with adrenal insufficiency; maintaining a registry of patients with endocrine diseases and disorders; updating and maintenance of information in registries, namely, administering a patient registry for patients with congenital adrenal hyperplasia; updating and maintenance of information in registries, namely, administering a patient registry for patients with adrenal insufficiency; updating and maintenance of information in registries, namely, administering a patient registry for patients with endocrine diseases and disorders
• Class 038 — Telecommunications services: Promoting awareness of congenital adrenal hyperplasia by providing a public online platform in the nature of an online forum to discuss congenital adrenal hyperplasia and coping strategies; Promoting awareness of adrenal insufficiency by providing a public online platform in the nature of an online forum to discuss adrenal insufficiency and coping strategies; Promoting awareness of endocrine diseases and disorders by providing a public online platform in the nature of an online forum to discuss endocrine diseases and disorders and coping strategies
• Class 042 — Scientific and technological services: Providing information about medical research; providing medical research information in the field of pharmaceuticals and congenital adrenal hyperplasia; providing medical research information in the field of pharmaceuticals and adrenal insufficiency; providing medical research information in the field of pharmaceuticals and endocrine diseases and disorders
• Class 044 — Medical, beauty and agricultural services: Providing medical information; providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia; providing medical information to patients, medical professionals, and insurance companies in the field of adrenal insufficiency; providing medical information to patients, medical professionals, and insurance companies in the field of endocrine diseases and disorders; online information services, namely, providing medical information in the field of congenital adrenal hyperplasia; online information services, namely, providing medical information in the field of adrenal insufficiency; online information services, namely, providing medical information in the field of endocrine diseases and disorders; Providing medical information in the nature of providing an in-person health forum for users to participate in discussions in the field of congenital adrenal hyperplasia; Providing medical information in the nature of providing an in-person health forum for users to participate in discussions in the field of adrenal insufficiency; Providing medical information in the nature of providing an in-person health forum for users to participate in discussions in the field of endocrine diseases and disorders

Owner

• Neurocrine Biosciences, Inc., San Diego, CA, US
• Neurocrine Biosciences, Inc., San Diego, CA, US

Prosecution history

• 03 Dec 2025 — SOU TEAS EXTENSION RECEIVED
• 22 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
• 22 Aug 2025 — TEAS REQUEST TO DIVIDE RECEIVED
• 03 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 08 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 08 Apr 2025 — PUBLISHED FOR OPPOSITION
• 02 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 20 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 20 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 20 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 14 Mar 2025 — LAW OFFICE PUBLICATION REVIEW COMPLETED
• 14 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 14 Mar 2025 — EXAMINER'S AMENDMENT ENTERED
• 14 Mar 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 14 Mar 2025 — EXAMINERS AMENDMENT E-MAILED